Headline
The latest stories from AHA Today.
The U.S. District Court of the Eastern District of Louisiana Sept. 27 ruled in favor of a LCMC Health and Tulane University partnership, concluding that the Certificate of Public Advantage granted by Louisiana exempts the transaction from federal antitrust laws.
Congress should urge the Department of Health and Human Services鈥 Office for Civil Right to immediately withdraw its new rule regarding so-called 鈥渙nline tracking technologies鈥 and enact full federal preemption to the HIPAA privacy framework, AHA told Senate Health, Education, Labor & Pensions鈥
A new infographic spotlights how the AHA鈥檚 suicide prevention learning collaborative, a partnership with the Centers for Disease Control and Prevention, helped 37 organizations advance suicide prevention and well-being for their health care workers.
The director and nurse manager for pediatric emergency mental health services at UMass Memorial Health in Massachusetts share how the health system is helping kids receive treatment that fits their needs.
鈥淓merging research has confirmed what hospitals and health systems have been saying again and again and again 鈥 that 2022 was among the most financially challenging year the hospital field has experienced, and that recovery remains challenging,鈥 writes AHA鈥檚 director of policy research and analysis鈥
The Centers for Medicare & Medicaid Services Sept. 26鈥痳eleased premium and cost-sharing information for Medicare Advantage and Part D prescription drug plans for the 2024 calendar year.
The Senate Sept. 26 voted 77-19 to begin debate on a continuing resolution that would continue funding for government programs through Nov. 17. The Senate is expected to vote on the measure this week.
The board of directors for the International Code Council has named Jonathan Flannery, senior associate director of advocacy for AHA鈥檚 American Society for Health Care Engineering, to a three-year term on the code development committee for the International Fire Code effective in January.
A recent paper funded by the National Institute for Health Care Management Foundation adds to the growing list of insurer-backed, bias-riddled research aimed at diverting attention away from that industry鈥檚 troubling practices, writes AHA General Counsel and Secretary Melinda Hatton
The Food and Drug Administration Sept. 26 finalized guidance updating the cybersecurity information device makers should submit to its Center for Devices and Radiological Health or Center for Biologics Evaluation and Research for premarket review of devices that have cybersecurity considerations.